Genetic epidemiology of hip and knee osteoarthritis

Nature Reviews Rheumatology

Volumn 7, Issue 1, 2011, Pages 23-32

  Valdes, Ana M ^a   Spector, Tim D ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN; CALMODULIN; CATECHOL METHYLTRANSFERASE; COLLAGEN TYPE 10; COLLAGEN TYPE 2; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH DIFFERENTIATION FACTOR 5; INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; KLOTHO PROTEIN; LEPTIN; MESSENGER RNA; PITUITARY HOMEOBOX 1; PROSTAGLANDIN E2; SMAD3 PROTEIN; SODIUM CHANNEL NAV1.7; THYROXINE DEIODINASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TYPE II IODOTHYRONINE DEIODINASE; TYPE III IODOTHYRONINE DEIODINASE; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; CHROMOSOME 7Q; EXTRACELLULAR MATRIX; FAMILY HISTORY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE MAP; HIP OSTEOARTHRITIS; HIP PAIN; HUMAN; KNEE OSTEOARTHRITIS; LINKAGE ANALYSIS; MITOCHONDRIAL DNA DISORDER; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROTEIN FUNCTION; PUBLIC HEALTH PROBLEM; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VARIABLE NUMBER OF TANDEM REPEAT;

COLLAGEN TYPE VI; GENETIC PREDISPOSITION TO DISEASE; GROWTH DIFFERENTIATION FACTOR 5; HUMANS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PROSTAGLANDINS; RISK FACTORS;

EID: 78650977864     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.191     Document Type: Review

References (116)

1. Dieppe, P. A. & Lohmander, L. S. Pathogenesis and management of pain in osteoarthritis. Lancet 365, 965-973 (2005).
2. Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26-35 (2008).
3. Katz, J. N. Total joint replacement in osteoarthritis. Best Pract. Res. Clin. Rheumatol. 20, 145-153 (2006).
4. Harrison, M. H., Shajowicz, F. & Trueta, J. Osteoarthritis of the hip: a study of the nature and evolution of the disease. J. Bone Joint Surg. Br. 35B, 598-626 (1953).
5. Stein, C. M. & Elston, R. C. Finding genes underlying human disease. Clin. Genet. 75, 101-106 (2009).
6. Valdes, A. M. et al. Involvement of different risk factors are involved in clinically severe large joint osteoarthritis according to the presence of hand interphalangeal nodes. Arthritis Rheum. 62, 2688-2695 (2010).
7. van Meurs, J. B. et al. A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum. 60, 628-629 (2009).
8. Kerkhof, H. J. et al. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum. 62, 499-510 (2010).
9. Gordon, A., Kiss-Toth, E., Stockley, I., Eastell, R. & Wilkinson, J. M. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum. 58, 3157-3165 (2008).
10. Borenstein, D. et al. Report of the American College of Rheumatology Pain Management Task Force. Arthritis Care Res. 62, 590-599 (2010).
11. Hunter, D. J., Le Graverand, M. P. & Eckstein, F. Radiologic markers of osteoarthritis progression. Curr. Opin. Rheumatol. 21, 110-117 (2009).
12. Reimann, F. et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc. Natl Acad. Sci. USA 107, 5148-5153 (2010).
13. Hunter, D. J., Snieder, H., March, L. & Sambrook, P. N. Genetic contribution to cartilage volume in women: a classical twin study. Rheumatology (Oxford) 42, 1495-1500 (2003).
14. Zhai, G., Ding, C., Stankovich, J., Cicuttini, F. & Jones, G. The genetic contribution to longitudinal changes in knee structure and muscle strength: a sibpair study. Arthritis Rheum. 52, 2830-2834 (2005).
15. Zhai, G., Hart, D. J., Kato, B. S., MacGregor, A. & Spector, T. D. Genetic influence on the progression of radiographic knee osteoarthritis, a longitudinal twin study. Osteoarthritis Cartilage 15, 222-225 (2007).
16. Lanyon, P., Muir, K., Doherty, S. & Doherty, M. Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. BMJ 321, 1179-1183 (2000).
17. Neame, R. L., Muir, K., Doherty, S. & Doherty, M. Genetic risk of knee osteoarthritis, a sibling study. Ann. Rheum. Dis. 63, 1022-1027 (2004).
18. Chitnavis, J. et al. Genetic influences in end-stage osteoarthritis. Sibling risks of hip and knee replacement for idiopathic osteoarthritis. J. Bone Joint Surg. Br. 79, 660-664 (1997).
19. Bukulmez, H. et al. Hip joint replacement surgery for idiopathic osteoarthritis aggregates in families. Arthritis Res. Ther. 8, R25 (2006).
20. McDonnell, S. M., Sinsheimer, J., Price, A. J. & Carr, A. J. Genetic influences in the aetiology of anteromedial osteoarthritis of the knee. J. Bone Joint Surg. Br. 89, 901-903 (2007).
21. Lee, Y. H., Rho, Y. H., Choi, S. J., Ji, J. D. & Song, G. G. Osteoarthritis susceptibility loci defined by genome scan meta-analysis. Rheumatol. Int. 26, 996-1000 (2006).
22. Meulenbelt, I. et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum. Mol. Genet. 17, 1867-1875 (2008).
23. The International HapMap Consortium International HapMap Project [online], http://hapmap.ncbi.nlm.nih.gov/ (2010).
24. Stark, K., Straub, R. H., Blazicková, S., Hengstenberg, C. & Rovenský, J. Genetics in neuroendocrine immunology: implications for rheumatoid arthritis and osteoarthritis. Ann. NY Acad. Sci. 1193, 10-14 (2010).
25. Halperin, E. & Stephan, D. A. SNP imputation in association studies. Nat. Biotechnol. 27, 349-351 (2009).
26. Johnson, A. D. & ODonnell, C. J. An open access database of genome-wide association results. BMC Med. Genet. 10, 6 (2009).
27. McClellan, J. & King, M. C. Genetic heterogeneity in human disease. Cell 141, 210-217 (2010).
28. 1,000 Genomes: a deep catalog of human genetic variation. The 1,000 Genomes Project [online], http://www.1000genomes.org/ (2010).
29. UK10K: rare genetic variants in health and disease. UK10K Project [online], http://www.uk10k.org/ (2010)
30. HuGE literature finder. HuGE Navigator [online], http://hugenavigator. net/HuGENavigator/ startPagePubLit.do (2010)
31. Ioannidis, J. P. Calibration of credibility of agnostic genome-wide associations. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 964-972 (2008).
32. Lories, R. J. Joint homeostasis, restoration, and remodeling in osteoarthritis. Best Pract. Res. Clin. Rheumatol. 22, 209-220 (2008).
33. Francis-West, P. H. et al. Mechanisms of GDF-5 action during skeletal development. Development 126, 1305-1315 (1999).
34. Miyamoto, Y. et al. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet. 39, 529-533 (2007).
35. Egli, R. J. et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum. 60, 2055-2064 (2009).
36. Valdes, A. M. et al. Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations. Ann. Rheum. Dis. 68, 1916-1920 (2009).
37. Evangelou, E. et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum. 60, 1710-1721 (2009).
38. Chapman, K. et al. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5′ UTR of GDF5 with osteoarthritis susceptibility. Hum. Mol. Genet. 17, 1497-1504 (2008).
39. Vaes, R. B. et al. Genetic variation in the GDF5 region is associated with osteoarthritis, height, hip axis length and fracture risk: the Rotterdam study. Ann. Rheum. Dis. 68, 1754-1760 (2009).
40. Valdes, A. M. et al. The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann. Rheum. Dis. doi:10.1136/ ard.2010.134155.
41. van den Berg, W. B. Lessons from animal models of osteoarthritis. Curr. Rheumatol. Rep. 10, 26-29 (2008).
42. Kizawa, H. et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat. Genet. 37, 138-144 (2005).
43. Jiang, Q. et al. Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese. J. Hum. Genet. 51, 1068-1072 (2006).
44. Shi, D. et al. Association of the aspartic acidrepeat polymorphism in the asporin gene with age at onset of knee osteoarthritis in Han Chinese population. J. Hum. Genet. 52, 664-667 (2007).
45. Song, J. H. et al. Aspartic acid repeat polymorphism of the asporin gene with susceptibility to osteoarthritis of the knee in a Korean population. Knee 15, 191-195 (2008).
46. Atif, U. et al. Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 16, 1174-1177 (2008).
47. Nakamura, T. et al. Meta-analysis of association between the ASPN D-repeat and osteoarthritis. Hum. Mol. Genet. 16, 1676-1681 (2007).
48. Yang, X. et al. TGF-α/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153, 35-46 (2001).
49. Valdes, A. M. et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum. 62, 2347-2352 (2010).
50. Li, T. F. et al. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J. Bone Miner. Res. 21, 4-16 (2006).
51. Eisenberg, M. & Distefano, J. J. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. Thyroid 19, 103-110 (2009).
52. Meulenbelt, I. et al. Meta-analyses of genes modulating intracellular T3 bio-availability reveal a possible role for the DIO3 gene in osteoarthritis susceptibility. Ann. Rheum. Dis. doi:10.1136/ard.2010.133660.
53. Regan, E. et al. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum. 52, 3479-3491 (2005).
54. Kim, H. A. & Blanco, F. J. Cell death and apoptosis in osteoarthritic cartilage. Curr. Drug Targets 8, 333-345 (2007).
55. Valdes, A. M. et al. Variation at the ANP32A gene is associated with risk of hip osteoarthritis in women. Arthritis Rheum. 60, 2046-2054 (2009).
56. Rego, I. et al. The role of European mtDNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann. Rheum. Dis. 69, 210-213 (2010).
57. Rego-Pérez, I., Fernández-Moreno, M., Fernández- Lpez, C., Arenas, J. & Blanco, F. J. Mitochondrial DNA haplogroups, role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum. 58, 2387-2396 (2008).
58. Gálvez-Rosas, A. et al. A COL2A1 gene polymorphism is related with advanced stages of osteoarthritis of the knee in Mexican Mestizo population. Rheumatol. Int. 30, 1035-1039 (2010)
59. Lamas, J. R. et al. Large-scale gene expression in bone marrow mesenchymal stem cells: a putative role for COL10A1 in osteoarthritis. Ann. Rheum. Dis. 69, 1880-1885 (2010).
60. Wagener, R., Gara, S. K., Kobbe, B., Paulsson, M. & Zaucke, F. The knee osteoarthritis susceptibility locus DVWA on chromosome 3p24.3 is the 5′ part of the split COL6A4 gene. Matrix Biol. 28, 307-310 (2009).
61. Miyamoto, Y. et al. Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis. Nat. Genet. 40, 994-998 (2008).
62. Meulenbelt, I. et al. Large replication study and meta-analyses of DVWA as an osteoarthritis susceptibility locus in European and Asian populations. Hum. Mol. Genet. 18, 1518-1523 (2009).
63. Abramson, S. B. & Attur, M. Developments in the scientific understanding of osteoarthritis. Arthritis Res. Ther. 11, 227 (2009).
64. Valdes, A. M. & Spector, T. D. The contribution of genes to osteoarthritis. Med. Clin. North Am. 93, 45-66 (2009).
65. Valdes, A. M. et al. A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthritis Cartilage 18, 699-704 (2010).
66. Attur, M. et al. Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations. Ann. Rheum. Dis. 69, 856-861 (2010).
67. Sezgin, M. et al. Lack of association polymorphisms of the IL1RN, IL1A, and IL1B genes with knee osteoarthritis in Turkish patients. Clin. Invest. Med. 30, E86-E92 (2007).
68. Kanoh, T. et al. Interleukin-1beta gene polymorphism associated with radiographic signs of osteoarthritis of the knee. J. Orthop. Sci. 13, 97-100 (2008).
69. Ni, H. et al. Genetic polymorphisms of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86-bpVNTR) in susceptibility to knee osteoarthritis in a Chinese Han population. Rheumatol. Int. 29, 1301-1305 (2009).
70. Valdes, A. M. et al. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am. J. Hum. Genet. 82, 1231-1240 (2008).
71. Schneider, E. M. et al. The (-765 G->C) promoter variant of the COX-2/PTGS2 gene is associated with a lower risk for end-stage hip and knee osteoarthritis. Ann. Rheum. Dis. doi:10.1136/ard.2009.124040.
72. Nakajima, M. et al. New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study. PLoS ONE 5, e9723 (2010).
73. Sakkas, L. I. & Platsoucas, C. D. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum. 56, 409-424 (2007).
74. Kerkhof, H. J. et al. Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index. Ann. Rheum. Dis. doi:10.1136/ard.2009.125260.
75. Sezgin, M. et al. Tumour necrosis factor alpha -308G/A gene polymorphism: lack of association with knee osteoarthritis in a Turkish population. Clin. Exp. Rheumatol. 26, 763-768 (2008).
76. Hartmann, C. & Tabin, C. J. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127, 3141-3159 (2000).
77. Corr, M. Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis. Nat. Clin. Pract. Rheumatol. 4, 550-556 (2008).
78. Smith, A. J. et al. Haplotypes of the lowdensity lipoprotein receptor-related protein 5 (LRP5) gene: are they a risk factor in osteoarthritis? Osteoarthritis Cartilage 13, 608-613 (2005).
79. Kerkhof, J. M. et al. Radiographic osteoarthritis at three joint sites and FRZB, LRP5, and LRP6 polymorphisms in two population-based cohorts. Osteoarthritis Cartilage 16, 1141-1149 (2008).
80. Lane, N. E. et al. Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 54, 1246-1254 (2006).
81. Valdes, A. M. et al. Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum. 56, 137-146 (2007).
82. Tortorella, M. D. & Malfait, A. M. The usual suspects: verdict not guilty? Arthritis Rheum. 48, 3304-3307 (2003).
83. Stanton, H. et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648-652 (2005).
84. Rodriguez-Lopez, J. et al. Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis. Arthritis Rheum. 58, 435-441 (2008).
85. Rodriguez-Lopez, J. et al. Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes. Osteoarthritis Cartilage 17, 321-327 (2009).
86. Barlas, I. O. et al. Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol. Int. 29, 383-388 (2009).
87. Kerna, I. et al. Missense single nucleotide polymorphism of the ADAM12 gene is associated with radiographic knee osteoarthritis in middle-aged Estonian cohort. Osteoarthritis Cartilage 17, 1093-1098 (2009).
88. Valdes, A. M. et al. Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum. 54, 533-539 (2006).
89. Jin, S. Y. et al. Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population. Arthritis Res. Ther. 6, R415-R421 (2004).
90. Tawonsawatruk, T. et al. Association of estrogen receptor-alpha single-nucleotide polymorphism (codon 594 G->A) and Thai patients affected by knee osteoarthritis. J. Med. Assoc. Thai. 92 (Suppl. 6), S45-S50 (2009).
91. Lian, K. et al. Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women. Osteoarthritis Cartilage 15, 972-978 (2007).
92. Limer, K. L. et al. Attempt to replicate published genetic associations in a large, welldefined osteoarthritis case-control population (the GOAL study). Osteoarthritis Cartilage 17, 782-789 (2009).
93. Mototani, H. et al. A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese. Hum. Mol. Genet. 17, 1790-1797 (2008).
94. Dieguez-Gonzalez, R. et al. Testing the druggable endothelial differentiation gene 2 knee osteoarthritis genetic factor for replication in a wide range of sample collections. Ann. Rheum. Dis. 68, 1017-1021 (2009).
95. Tsezou, A. et al. Association of KLOTHO gene polymorphisms with knee osteoarthritis in Greek population. J. Orthop. Res. 26, 1466-1470 (2008).
96. Picard, C., Azeddine, B., Moldovan, F., Martel- Pelletier, J. & Moreau, A. New emerging role of pitx1 transcription factor in osteoarthritis pathogenesis. Clin. Orthop. Relat. Res. 462, 59-66 (2007).
97. Fan, J. et al. Genetic polymorphism of PITX1 in susceptibility to knee osteoarthritis in a Chinese Han population: a case-control study. Rheumatol. Int. doi:10.1007/s00296-009- 1341-5.
98. Mototani, H. et al. A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Hum. Mol. Genet. 14, 1009-1017 (2005).
99. Poulou, M. et al. Association of the CALM1 core promoter polymorphism with knee osteoarthritis in patients of Greek origin. Genet. Test. 12, 263-265 (2008).
100. Shi, D. et al. Lack of association between the CALM1 core promoter polymorphism (-16C/T) and susceptibility to knee osteoarthritis in a Chinese Han population. BMC Med. Genet. 9, 91 (2008).
101. Mototani, H., Iida, A., Nakamura, Y. & Ikegawa, S. Identification of sequence polymorphisms in CALM2 and analysis of association with hip osteoarthritis in a Japanese population. J. Bone Miner. Metab. 28, 547-553 (2010).
102. Hong, S. J. et al. Angiotensin converting enzyme gene polymorphism in Korean patients with primary knee osteoarthritis. Exp. Mol. Med. 35, 189-195 (2003).
103. Bayram, B. et al. DD genotype of ace gene I/D polymorphism is associated in a Turkish study population with osteoarthritis. Mol. Biol. Rep. doi:10.1007/s11033-010-0284-y.
104. Shehab, D. K. et al. Prevalence of angiotensinconverting enzyme gene insertion-deletion polymorphism in patients with primary knee osteoarthritis. Clin. Exp. Rheumatol. 26, 305-310 (2008).
105. Karsdal, M. A. et al. Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann. NY Acad. Sci. 1117, 181-195 (2007).
106. Magaña, J. J. et al. Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Knee 17, 157-160 (2010).
107. Katz, J. D., Agrawal, S. & Velasquez, M. Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome. Curr. Opin. Rheumatol. 22, 512-519 (2010)
108. Mutabaruka, M. S., Aoulad Aissa, M., Delalandre, A., Lavigne, M. & Lajeunesse, D. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res. Ther. 12, R20 (2010).
109. Qin, J. et al. Association of the leptin gene with knee osteoarthritis susceptibility in a Han Chinese population: a case-control study. J. Hum. Genet. doi:10.1038/jhg.2010.86.
110. Sánchez-Enrquez, S. et al. Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF -460 T/C and +405 C/G polymorphisms. Rheumatol. Int. 29, 63-68 (2008)
111. Shi, D. et al. Association of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a metaanalysis. Arthritis Res. Ther. 10, R54 (2008).
112. Jiang, Q. et al. Lack of association of single nucleotide polymorphism in LRCH1 with knee osteoarthritis susceptibility. J. Hum. Genet. 53, 42-47 (2008).
113. Evangelou, E. et al. Meta-analysis of genomewide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann. Rheum. Dis. (in press).
114. Eichler, E. E. et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11, 446-450 (2010).
115. Valdes, A. M., Doherty, M. & Spector, T. D. The additive effect of individual genes in predicting risk of knee osteoarthritis. Ann. Rheum. Dis. 67, 124-127 (2008).
116. Takahashi, H. et al. Prediction model for knee osteoarthritis based on genetic and clinical information. Arthritis Res. Ther. 12, R187 (2010).